Related references
Note: Only part of the references are listed.Expression of CD164 on Malignant T Cells in Sezary Syndrome
Emmanuella Guenova et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma
Salvia Jain et al.
BLOOD (2015)
Differential expression of TOX by skin-infiltrating T cells in Sezary syndrome and erythrodermic dermatitis
Stephanie E. Boonk et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2015)
miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions
Elisa Penna et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
CD158k Is a Reliable Marker for Diagnosis of Sezary Syndrome and Reveals an Unprecedented Heterogeneity of Circulating Malignant Cells
Helene Moins-Teisserenc et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma
Yuanshen Huang et al.
BLOOD (2015)
TOX expression in different subtypes of cutaneous lymphoma
Sohshi Morimura et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
CD164 and FCRL3 Are Highly Expressed on CD4+CD26-T Cells in Sezary Syndrome Patients
Maria Wysocka et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma
Ivan V. Litvinov et al.
ONCOIMMUNOLOGY (2014)
TH2 Cytokines from Malignant Cells Suppress TH1 Responses and Enforce a Global TH2 Bias in Leukemic Cutaneous T-cell Lymphoma
Emmanuella Guenova et al.
CLINICAL CANCER RESEARCH (2013)
CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis
Ai-Fang Huang et al.
MOLECULAR CANCER (2013)
Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma
Elodie Begue et al.
BLOOD (2012)
Inhibiting CD164 Expression in Colon Cancer Cell Line HCT116 Leads to Reduced Cancer Cell Proliferation, Mobility, and Metastasis in vitro and in vivo
Jingqun Tang et al.
CANCER INVESTIGATION (2012)
The many roles of TOX in the immune system
Parinaz Aliahmad et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes
Felicia Leccia et al.
CYTOMETRY PART A (2012)
Increased Twist expression in advanced stage of mycosis fungoides and Sezary syndrome
Meghali Goswami et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2012)
Sezary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-β on the cell surface
Jin-Sung Chung et al.
BLOOD (2011)
New markers for minimal residual disease detection in acute lymphoblastic leukemia
Elaine Coustan-Smith et al.
BLOOD (2011)
Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Elise A. Olsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Expression and Function of the Natural Cytotoxicity Receptor NKp46 on Circulating Malignant CD4+ T Lymphocytes of Sezary Syndrome Patients
Armand Bensussan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome
M. G. Narducci et al.
CELL DEATH & DISEASE (2011)
MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential
Erica Ballabio et al.
BLOOD (2010)
Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors
James J. Campbell et al.
BLOOD (2010)
The role of 9-O-acetylated ganglioside D3 (CD60) and α4β1 (CD49d) expression in predicting the survival of patients with Sezary syndrome
Enrico Scala et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Costimulation-Dependent Expression of MicroRNA-214 Increases the Ability of T Cells To Proliferate by Targeting Pten
Peter T. Jindra et al.
JOURNAL OF IMMUNOLOGY (2010)
TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214
G. Yin et al.
ONCOGENE (2010)
Fc Receptor-Like 3 Protein Expressed on IL-2 Nonresponsive Subset of Human Regulatory T Cells
Satoshi Nagata et al.
JOURNAL OF IMMUNOLOGY (2009)
Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation
Jin-Sung Chung et al.
JOURNAL OF IMMUNOLOGY (2007)
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
A. M. Havens et al.
BMC CANCER (2006)
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy
M Nebozhyn et al.
BLOOD (2006)
Absence of CD26 expression on skin-homing CLA+CD4+T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sezary syndrome
M Sokolowska-Wojdylo et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2005)
Immunopathogenesis and therapy of cutaneous T cell lymphoma
EJ Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
MUC1 mucin-mediated regulation of human T cells
B Agrawal et al.
INTERNATIONAL IMMUNOLOGY (2005)
CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells:: Relevance for the diagnosis and follow-up of Sezary syndrome
E Poszepczynska-Guigné et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis
R van Doorn et al.
CANCER RESEARCH (2004)
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma
L Kari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma
N Yawalkar et al.
BLOOD (2003)
Increased CCR4 expression in cutaneous T cell lymphoma
K Ferenczi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
The ratio of splicing variants of MGC-24/CD164, a sialomucin, correlates with the metastatic potential of colorectal carcinomas
T Matsui et al.
JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
